Guttate Psoriasis clinical trials at UCSF

1 research study open to eligible people

Guttate psoriasis is a type of psoriasis that results in small, red spots on the skin. UCSF is running a trial to explore the effects of guselkumab on individuals with this skin condition. The study investigates both the skin's clinical response and genetic factors.

Showing trials for

  • Guselkumab Immunogenetics

    open to eligible people ages 18 years and up

    This is a two-arm open-label study to evaluate the clinical and immunogenetic responses of patients with plaque or guttate psoriasis to treatment with guselkumab.

    San Francisco, California

Our lead scientists for Guttate Psoriasis research studies include .

Last updated: